Cargando…
Clinical Utility of β(3)-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations
This nonsystematic review provides a summary of current evidence on the use of β(3)-adrenoreceptor agonists (β(3)-ARAs) for the treatment for lower urinary tract symptoms. Soon after their discovery in 1989, β(3)-ARs were identified as a predominant adrenoreceptor subtype in the human urinary bladde...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056051/ https://www.ncbi.nlm.nih.gov/pubmed/35502186 http://dx.doi.org/10.2147/RRU.S309144 |